Skip to content

OrthoPediatrics KIDS Sports medicine/other — Net revenue

Other product segments

Trauma and deformity
$43.05M+13.7%
Scoliosis
$15.44M+13.0%

Similar metrics at other companies

Stryker logo
SYKOther Orthopedics — Net Sales
$157M+18.0%
CONMED logo
CNMDOrthopedic Surgery — Net Sales
$147.66M+6.8%
Academy Sports and Outdoors logo
ASOSports and recreation — Net Sales
$355.95M+6.2%
Baxter International logo
BAXMedical Products & Therapies — Net Sales
$1.29B+1.8%
OraSure Technologies logo
OSURProducts and services — Net revenues
$26.38M-9.0%
Vertex Pharmaceuticals logo
VRTXOther revenues — Product revenues, net
$0-100%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's sports medicine/other — net revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's sports medicine/other — net revenue?
OrthoPediatrics (KIDS) reported sports medicine/other — net revenue of $875K in Q1 2026.
How has OrthoPediatrics's sports medicine/other — net revenue changed year-over-year?
OrthoPediatrics's sports medicine/other — net revenue decreased by 0.6% year-over-year, from $880K to $875K.
What is the long-term trend for OrthoPediatrics's sports medicine/other — net revenue?
Over 4 years (2021 to 2025), OrthoPediatrics's sports medicine/other — net revenue has grown at a -1.1% compound annual growth rate (CAGR), from $4.17M to $4M.
What does sports medicine/other — net revenue mean?
This metric represents the total net revenue generated from the sale of products and services within the company's sports medicine and miscellaneous product categories. It reflects the market demand and commercial performance of specialized orthopedic solutions outside of the core pediatric implant business. Tracking this revenue stream helps investors assess the company's diversification strategy and the growth potential of its secondary product lines.